TY  - JOUR

T1  - Cabazitaxel for Hormone-Relapsed Metastatic Prostate Cancer Previously Treated With a Docetaxel-Containing Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

JO  - PharmacoEconomics

UR  - http://eprints.whiterose.ac.uk/108856/

UR  - http://www.readcube.com/articles/10.1007/s40273-016-0457-1?author_access_token=rbXYVuOBuR58SeGgHskhpve4RwlQNchNByi7wbcMAY6MEWC31o0d4h78u4fova25uJYul-_IVvaUf5Ko-2nnX0OFXNZYPoqEMa_zYnT2yqE2DtYjUUNVTAI-S

PY  - 2016/10/22

AU  - Kearns B

AU  - Pandor A

AU  - Stevenson M

AU  - Hamilton J

AU  - Chambers D

AU  - Clowes M

AU  - Graham J

AU  - Kumar MS

ED  - 

DO  - DOI: 10.1007/s40273-016-0457-1

PB  - Adis

VL  - 35

IS  - 4

SP  - 415

EP  - 424

Y2  - 2024/12/22

ER  -